Stocks
Arrowhead Pharmaceuticals (ARWR) Debt/EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| Debt/EBITDA | -3.94 | 3.37 | 2.43 | 1.65 | -0.02 | 0.28 | ||
| Changes by years, y/y, % | -374% | -186% | -28% | -32% | -101% | |||
Arrowhead Pharmaceuticals. Debt/EBITDA
Arrowhead Pharmaceuticals. Debt/EBITDA, changes, %
Arrowhead Pharmaceuticals (ARWR) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| Debt/EBITDA | 2.83 | 2.23 | 1.59 | 0.38 | 0.28 | 0.28 | ||
| Changes by years, y/y, % | -21% | -2% | -8% | -86% | -90% | |||
| Changes by quarters, q/q, % | +2% | -21% | -29% | -76% | -27% | |||
